海正藥業(600267.SH):海正杭州公司掛牌出售杭州市鹿山大樓
格隆匯8月26日丨海正藥業(600267.SH)公佈,為盤活閒置資產,提高資產運營效率,公司控股子公司海正藥業(杭州)有限公司(以下簡稱“海正杭州公司”)將以評估值為依據通過產權交易機構公開掛牌出售位於杭州市富陽鹿山新區的新建辦公大樓(鹿山大樓)。
公司已於2019年8月26日向台州市產權交易所有限公司(以下簡稱“台交所”)提交了杭州富陽鹿山街道江波街169號辦公樓的掛牌申請,相關房產將委託台交所通過掛牌方式轉讓。
台交所將於2019年8月27日在其網站上發佈《杭州富陽鹿山街道江波街169號辦公樓房產轉讓文件》,包括《產權轉讓公告》,並由台交所組織實施交易,掛牌自2019年8月27日至2019年9月24日16:00時止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.